These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 27847992)

  • 21. Early detection of occult atrial fibrillation and stroke prevention.
    Keach JW; Bradley SM; Turakhia MP; Maddox TM
    Heart; 2015 Jul; 101(14):1097-102. PubMed ID: 25935765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey.
    Potpara TS; Pison L; Larsen TB; Estner H; Madrid A; Blomström-Lundqvist C;
    Europace; 2015 Mar; 17(3):468-72. PubMed ID: 25722478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [How to manage anticoagulation in atrial fibrillation ablation].
    Amara W; Mlayeh D
    Ann Cardiol Angeiol (Paris); 2018 Nov; 67(5):370-373. PubMed ID: 30297078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.
    Lip GYH; Banerjee A; Boriani G; Chiang CE; Fargo R; Freedman B; Lane DA; Ruff CT; Turakhia M; Werring D; Patel S; Moores L
    Chest; 2018 Nov; 154(5):1121-1201. PubMed ID: 30144419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is it safe to stop oral anticoagulation after catheter ablation for atrial fibrillation?
    Romero J; Avendano R; Diaz JC; Taveras J; Lupercio F; Di Biase L
    Expert Rev Cardiovasc Ther; 2019 Jan; 17(1):31-41. PubMed ID: 30460874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.
    Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P;
    Eur Heart J; 2017 Jul; 38(27):2137-2149. PubMed ID: 27282612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the 2010 North American and European atrial fibrillation guidelines.
    Gillis AM; Skanes AC
    Can J Cardiol; 2011; 27(1):7-13. PubMed ID: 21329856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulation in atrial fibrillation: a contemporary viewpoint.
    Wyse DG
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S34-9. PubMed ID: 17336882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.
    Black-Maier E; Kim S; Steinberg BA; Fonarow GC; Freeman JV; Kowey PR; Ansell J; Gersh BJ; Mahaffey KW; Naccarelli G; Hylek EM; Go AS; Peterson ED; Piccini JP;
    Clin Cardiol; 2017 Sep; 40(9):746-751. PubMed ID: 28543401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Consensus statement: Stroke prevention in nonvalvular atrial fibrillation in special consideration of the new direct oral anticoagulants].
    Pabinger I; Lang W; Roithinger FX; Weidinger F; Eichinger-Hasenauer S; Glehr R; Halbmayer WM; Haring HP; Jilma B; Korninger HC; Kozek-Langenecker S; Kyrle P; Watzke H; Weltermann A; Willeit J; Huber K; ; ; ; ; ;
    Wien Klin Wochenschr; 2014 Dec; 126(23-24):792-808. PubMed ID: 25277828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey.
    Dan GA; Iliodromitis K; Scherr D; Marín F; Lenarczyk R; Estner HL; Kostkiewicz M; Dagres N; Lip GYH
    Europace; 2018 Aug; 20(8):1382-1387. PubMed ID: 29893840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry.
    Cools F; Wollaert B; Vervoort G; Verstraete S; Voet J; Hermans K; Heyse A; De Wolf A; Hollanders G; Boussy T; Anné W; Vercammen J; Faes D; Beutels M; Mairesse G; Purnode P; Blankoff I; Vandergoten P; Capiau L; Allu J; Bassand JP; Kayani G;
    Acta Cardiol; 2019 Aug; 74(4):309-318. PubMed ID: 30369290
    [No Abstract]   [Full Text] [Related]  

  • 33. [Oral anticoagulation for atrial fibrillation].
    Antz M; Beauport J; Vocke W
    Herzschrittmacherther Elektrophysiol; 2014 Mar; 25(1):3-11. PubMed ID: 24562906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Modern risk assessment and stroke prevention in atrial fibrillation].
    Gerber B; Senn O
    Praxis (Bern 1994); 2011 Sep; 100(19):1161-72. PubMed ID: 21938710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
    Dupree L; DeLosSantos M; Smotherman C
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.
    Heidbuchel H; Verhamme P; Alings M; Antz M; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
    Eur Heart J; 2013 Jul; 34(27):2094-106. PubMed ID: 23625209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Not Available].
    Eckardt L; Wasmer K
    Dtsch Med Wochenschr; 2017 Oct; 142(20):1520-1524. PubMed ID: 29017209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current atrial fibrillation guidelines and therapy algorithms: are they adequate?
    Lévy S
    J Interv Card Electrophysiol; 2009 Aug; 25(2):111-6. PubMed ID: 18975067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
    Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
    Europace; 2015 Oct; 17(10):1467-507. PubMed ID: 26324838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.
    Hohnloser SH; Camm J; Cappato R; Diener HC; Heidbuchel H; Lanz HJ; Mont L; Morillo CA; Smolnik R; Yin OQP; Kautzner J
    Clin Cardiol; 2018 Apr; 41(4):440-449. PubMed ID: 29663464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.